| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$2,287,978,695 |
|
|
|
Indirect Value
|
$9,597,179 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$2,297,575,874 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
17
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
8.5
|
0.0
|
| Percentage
Gain/Loss : |
 31.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SMMT |
Summit Therapeutics Inc |
See RemarksOfficer |
• • • |
2020-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,224,677 |
|
% |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • • |
2020-11-06 |
4 |
B |
$3.34 |
$46,999,999 |
D/D |
14,071,856 |
56,296,533 |
3.23 |
% |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • • |
2021-05-12 |
4 |
B |
$5.24 |
$59,557,426 |
D/D |
11,365,921 |
67,662,454 |
3.23 |
% |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
21,135 |
67,683,589 |
0 |
- |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-08-16 |
4 |
B |
$0.97 |
$92,003,727 |
D/D |
94,849,203 |
162,532,792 |
2.81 |
% |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,346,434 |
171,879,226 |
0 |
- |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2023-03-06 |
4 |
B |
$1.05 |
$395,314,374 |
D/D |
376,489,880 |
552,354,161 |
2.81 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-02-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,131,735 |
|
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-02-09 |
4 |
B |
$11.64 |
$484,503 |
D/D |
41,624 |
2,173,359 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-03-16 |
4 |
B |
$22.54 |
$1,782,352 |
D/D |
73,782 |
2,247,141 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-03-17 |
4 |
B |
$24.07 |
$622,452 |
D/D |
25,859 |
2,273,000 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-03-18 |
4 |
B |
$23.01 |
$2,427,127 |
D/D |
105,486 |
2,378,486 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-06 |
4 |
B |
$18.54 |
$1,263,921 |
D/D |
65,400 |
2,452,886 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-07 |
4 |
B |
$19.59 |
$1,843,795 |
D/D |
94,100 |
2,546,986 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-10 |
4 |
B |
$20.38 |
$674,531 |
D/D |
31,964 |
2,578,950 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-17 |
4 |
B |
$23.15 |
$2,661,945 |
D/D |
107,300 |
2,686,250 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-18 |
4 |
B |
$25.06 |
$1,576,025 |
D/D |
61,819 |
2,748,069 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-19 |
4 |
B |
$22.24 |
$3,567,743 |
D/D |
150,123 |
2,898,192 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-25 |
4 |
B |
$24.94 |
$628,113 |
D/D |
25,187 |
2,923,379 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-26 |
4 |
B |
$24.47 |
$244,690 |
D/D |
10,000 |
2,933,379 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-27 |
4 |
B |
$22.95 |
$4,590 |
D/D |
200 |
2,933,579 |
2.37 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-28 |
4 |
B |
$24.00 |
$840,000 |
I/I |
35,000 |
35,000 |
1.5 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-28 |
4 |
B |
$23.85 |
$596,250 |
D/D |
25,000 |
2,958,579 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-05-01 |
4 |
B |
$23.81 |
$460,715 |
D/D |
19,348 |
2,977,927 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-05-02 |
4 |
B |
$23.40 |
$117,000 |
D/D |
5,000 |
2,982,927 |
2.45 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
